|
100
|
Biological Containment Isolation System (BCIS)
W911QY-26-S-BCIS-01 · DEPT OF THE ARMY · W6QK ACC-APG NATICK · commercialization
|
biomedical clinical
national security defense
materials manufacturing
|
— |
2026-06-11 |
2026-07-07 |
0 |
|
100
|
National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2027
75N91026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI · commercialization
|
biomedical clinical
public health
ai data science
|
— |
2026-07-02 |
2026-07-17 |
10 |
|
100
|
TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
S-195061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-15 |
2026-12-15 |
161 |
|
100
|
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
S-194657 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-17 |
2026-12-17 |
163 |
|
100
|
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
PA-27-102 · National Institutes of Health · commercialization
|
biomedical clinical
materials manufacturing
ai data science
|
— |
2026-05-28 |
2027-04-05 |
272 |
|
100
|
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
PA-27-100 · National Institutes of Health · commercialization
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-28 |
2027-04-05 |
272 |
|
100
|
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
PA-27-101 · National Institutes of Health · commercialization
|
biomedical clinical
economic development
|
— |
2026-05-28 |
2029-04-05 |
1003 |
|
100
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
PAR-27-098 · National Institutes of Health · commercialization
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-28 |
2029-04-05 |
1003 |
|
60
|
Biological Containment Isolation System (BCIS)
W911QY-26-S-BCIS-01 · DEPT OF THE ARMY · W6QK ACC-APG NATICK · commercialization
|
biomedical clinical
materials manufacturing
emergency disaster resilience
|
— |
2026-06-26 |
2026-07-07 |
0 |
|
60
|
Biological Containment Isolation System (BCIS)
W911QY-26-S-BCIS-01 · DEPT OF THE ARMY · W6QK ACC-APG NATICK · commercialization
|
biomedical clinical
national security defense
materials manufacturing
|
— |
2026-07-01 |
2026-07-10 |
3 |
|
60
|
Repurposing Equipment for Drug Delivery (REDD)
REDD · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA · commercialization
|
biomedical clinical
materials manufacturing
public health
|
— |
2026-06-29 |
2026-07-23 |
16 |
|
60
|
Request for Project Proposals: “PRimer and prObe Manufacturing PlaTform (PROMPT)”
MTEC-26-03-PROMPT · DEFENSE HEALTH AGENCY (DHA) · ARMY MED RES ACQ ACTIVITY · commercialization
|
biomedical clinical
national security defense
materials manufacturing
|
— |
2026-06-25 |
2026-07-24 |
17 |
|
60
|
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
75A50126R00002 · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA · commercialization
|
biomedical clinical
public health
emergency disaster resilience
|
— |
2026-07-06 |
2026-07-30 |
23 |
|
60
|
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
75A50126R00002 · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA · commercialization
|
biomedical clinical
public health
emergency disaster resilience
|
— |
2026-07-02 |
2026-07-30 |
23 |
|
60
|
Battlefield Pain Management – Analgesic
HT942726RE009 · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · commercialization
|
biomedical clinical
national security defense
|
— |
2026-06-29 |
2026-07-30 |
23 |
|
60
|
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
75A50126R00002 · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA · commercialization
|
biomedical clinical
public health
emergency disaster resilience
|
— |
2026-06-16 |
2026-07-30 |
23 |
|
60
|
DoW Peer Reviewed Medical, Technology/Therapeutic Development Award
HT942526PRMRPTTDA · Defense Health Agency Contracting Activity - DHACA · commercialization
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-08 |
2026-08-06 |
30 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro
S-196061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
ai data science
materials manufacturing
|
— |
2026-06-05 |
2026-12-05 |
151 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
S-191192 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
materials manufacturing
national security defense
|
— |
2026-06-15 |
2026-12-15 |
161 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
S-194657 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-17 |
2026-12-17 |
163 |
|
60
|
TECHNOLOGY LICENSING OPPORTUNITY: Selective Separation
S-167732 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
materials manufacturing
energy
agriculture food
|
— |
2026-04-07 |
2027-04-24 |
291 |
|
60
|
DEVCOM-SC BOTAA 22-01
DEVCOMBOTAA22-01 · DEPT OF THE ARMY · W6QK ACC-APG NATICK · commercialization
|
national security defense
materials manufacturing
biomedical clinical
|
— |
2022-06-09 |
2027-06-08 |
336 |
|
60
|
NSF National Innovation Corps Teams (NSF National I-Corps (TM) Teams) program
25-549 · U.S. National Science Foundation · commercialization
|
materials manufacturing
computing communications
energy
|
— |
2025-09-26 |
— |
— |
|
60
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · commercialization
|
biomedical clinical
national security defense
public health
|
— |
2026-05-06 |
— |
— |
|
60
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG · commercialization
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
60
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
· DEPT OF DEFENSE · commercialization
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
45
|
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
S-191192 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
biomedical clinical
|
— |
2026-06-15 |
2026-12-15 |
161 |
|
5
|
TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
S-195061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR · commercialization
|
biomedical clinical
public health
national security defense
|
— |
2026-06-15 |
2026-12-15 |
161 |